Magnetic Resonance Elastography for Assessing Fibrosis in Patients with Crohn's Disease: A Pilot Study.


Journal

Digestive diseases and sciences
ISSN: 1573-2568
Titre abrégé: Dig Dis Sci
Pays: United States
ID NLM: 7902782

Informations de publication

Date de publication:
09 2022
Historique:
received: 23 07 2021
accepted: 01 11 2021
pubmed: 22 11 2021
medline: 9 8 2022
entrez: 21 11 2021
Statut: ppublish

Résumé

Patients with Crohn's disease can develop intestinal strictures, containing various degrees of inflammation and fibrosis. Differentiation of the main component of a stricturing lesion is the key for defining the therapeutic management. We assessed for the first time the accuracy of magnetic resonance elastography in detecting intestinal fibrosis and predicting clinical course in patients with Crohn's disease. This was a prospective study of adult patients with Crohn's disease and magnetic resonance imaging examination, including magnetic resonance elastography, between April 2019 and February 2020. The association between the bowel stiffness value and the degree of fibrosis was evaluated. The relationship between the stiffness value and the occurrence of clinical events was also investigated. A total of 69 patients were included. The stiffness value measured by magnetic resonance elastography was correlated with the degree of fibrosis (p < 0.001). A bowel stiffness ≥ 3.57 kPa predicted the occurrence of clinical events with an area under the curve of 0.82 (95% CI 0.71-0.93). Bowel stiffness ≥ 3.57 kPa was associated with an increased risk of clinical events (p < 0.0001). In Crohn's disease, magnetic resonance elastography is a reliable tool for detecting intestinal fibrosis and predicting a worse disease outcome.

Sections du résumé

BACKGROUND
Patients with Crohn's disease can develop intestinal strictures, containing various degrees of inflammation and fibrosis. Differentiation of the main component of a stricturing lesion is the key for defining the therapeutic management.
AIMS
We assessed for the first time the accuracy of magnetic resonance elastography in detecting intestinal fibrosis and predicting clinical course in patients with Crohn's disease.
METHODS
This was a prospective study of adult patients with Crohn's disease and magnetic resonance imaging examination, including magnetic resonance elastography, between April 2019 and February 2020. The association between the bowel stiffness value and the degree of fibrosis was evaluated. The relationship between the stiffness value and the occurrence of clinical events was also investigated.
RESULTS
A total of 69 patients were included. The stiffness value measured by magnetic resonance elastography was correlated with the degree of fibrosis (p < 0.001). A bowel stiffness ≥ 3.57 kPa predicted the occurrence of clinical events with an area under the curve of 0.82 (95% CI 0.71-0.93). Bowel stiffness ≥ 3.57 kPa was associated with an increased risk of clinical events (p < 0.0001).
CONCLUSION
In Crohn's disease, magnetic resonance elastography is a reliable tool for detecting intestinal fibrosis and predicting a worse disease outcome.

Identifiants

pubmed: 34802092
doi: 10.1007/s10620-021-07311-9
pii: 10.1007/s10620-021-07311-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4518-4524

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Roda G, Chien Ng S, Kotze PG et al. Crohn’s disease. Nat Rev Dis Primers. 2020;6:22.
doi: 10.1038/s41572-020-0156-2
Peyrin-Biroulet L, Loftus EV, Colombel J-F, Sandborn WJ. The natural history of adult Crohn’s disease in population-based cohorts. Am J Gastroenterol. 2010;105:289–297.
doi: 10.1038/ajg.2009.579
Louis E, Collard A, Oger AF et al. Behaviour of Crohn’s disease according to the Vienna classification: changing pattern over the course of the disease. Gut. 2001;49:777–782.
doi: 10.1136/gut.49.6.777
Thia KT, Sandborn WJ, Harmsen WS et al. Risk factors associated with progression to intestinal complications of Crohn’s disease in a population-based cohort. Gastroenterology. 2010;139:1147–1155.
doi: 10.1053/j.gastro.2010.06.070
Maaser C, Sturm A, Vavricka SR et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis. 2019;13:144–164.
doi: 10.1093/ecco-jcc/jjy113
Allocca M, Danese S, Laurent V, Peyrin-Biroulet L. Use of Cross-Sectional Imaging for Tight Monitoring of Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2020;18:1309-1323.e4.
doi: 10.1016/j.cgh.2019.11.052
Lichtenstein GR, Loftus EV, Isaacs KL et al. ACG Clinical Guideline: Management of Crohn’s Disease in Adults. Am J Gastroenterol. 2018;113:481–517.
doi: 10.1038/ajg.2018.27
Hordonneau C, Buisson A, Scanzi J et al. Diffusion-weighted magnetic resonance imaging in ileocolonic Crohn’s disease: validation of quantitative index of activity. Am J Gastroenterol. 2014;109:89–98.
doi: 10.1038/ajg.2013.385
Rimola J, Rodriguez S, García-Bosch O et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease. Gut. 2009;58:1113–1120.
doi: 10.1136/gut.2008.167957
Puylaert CAJ, Nolthenius CJT, Tielbeek JAW et al. Comparison of MRI Activity Scoring Systems and Features for the Terminal Ileum in Patients With Crohn Disease. AJR Am J Roentgenol. 2019;212:W25–W31.
doi: 10.2214/AJR.18.19876
Yin M, Talwalkar JA, Glaser KJ et al. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol. 2007;5:1207-1213.e2.
doi: 10.1016/j.cgh.2007.06.012
Serai SD, Yin M. MR Elastography of the Abdomen: Basic Concepts. Methods Mol Biol. 2021;2216:301–323.
doi: 10.1007/978-1-0716-0978-1_18
Venkatesh SK, Yin M, Ehman RL. Magnetic resonance elastography of liver: technique, analysis, and clinical applications. J Magn Reson Imaging. 2013;37:544–555.
doi: 10.1002/jmri.23731
Baumgart DC, Müller HP, Grittner U et al. US-based Real-time Elastography for the Detection of Fibrotic Gut Tissue in Patients with Stricturing Crohn Disease. Radiology. 2015;275:889–899.
doi: 10.1148/radiol.14141929
Fraquelli M, Branchi F, Cribiù FM et al. The Role of Ultrasound Elasticity Imaging in Predicting Ileal Fibrosis in Crohn’s Disease Patients. Inflamm Bowel Dis. 2015;21:2605–2612.
doi: 10.1097/MIB.0000000000000536
Chen Y-J, Mao R, Li X-H et al. Real-Time Shear Wave Ultrasound Elastography Differentiates Fibrotic from Inflammatory Strictures in Patients with Crohn’s Disease. Inflamm Bowel Dis. 2018;24:2183–2190.
doi: 10.1093/ibd/izy115
Manduca A, Bayly PJ, Ehman RL et al. MR elastography: Principles, guidelines, and terminology. Magn Reson Med. 2021;85:2377–2390.
doi: 10.1002/mrm.28627
QIBA MR Biomarker Committee. MR Elastography of the Liver, Quantitative Imaging Biomarkers Alliance. Profile Stage: Consensus. June 6, 2019. Available from: http://qibawiki.rsna.org/index.php/Profiles
Robin X, Turck N, Hainard A et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.
doi: 10.1186/1471-2105-12-77
Bettenworth D, Bokemeyer A, Baker M et al. Assessment of Crohn’s disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review. Gut. 2019;68:1115–1126.
doi: 10.1136/gutjnl-2018-318081
Veyrieres J-B, Albarel F, Lombard JV et al. A threshold value in Shear Wave elastography to rule out malignant thyroid nodules: a reality? Eur J Radiol. 2012;81:3965–3972.
doi: 10.1016/j.ejrad.2012.09.002
Bamber J, Cosgrove D, Dietrich CF, et al. EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: Basic principles and technology. Ultraschall Med. 2013;34:169–184.
Singh S, Venkatesh SK, Wang Z et al. Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. Clin Gastroenterol Hepatol. 2015;13:440-451.e6.
doi: 10.1016/j.cgh.2014.09.046
Wang J, Shan Q, Liu Y et al. 3D MR Elastography of Hepatocellular Carcinomas as a Potential Biomarker for Predicting Tumor Recurrence. J Magn Reson Imaging. 2019;49:719–730.
doi: 10.1002/jmri.26250
Balleyguier C, Lakhdar AB, Dunant A, et al. Value of whole breast magnetic resonance elastography added to MRI for lesion characterization. NMR Biomed. 2018;31.
Dittmann F, Reiter R, Guo J et al. Tomoelastography of the prostate using multifrequency MR elastography and externally placed pressurized-air drivers. Magn Reson Med. 2018;79:1325–1333.
doi: 10.1002/mrm.26769
Kolipaka A, Schroeder S, Mo X et al. Magnetic resonance elastography of the pancreas: Measurement reproducibility and relationship with age. Magn Reson Imaging. 2017;42:1–7.
doi: 10.1016/j.mri.2017.04.015
Serai SD, Abu-El-Haija M, Trout AT. 3D MR elastography of the pancreas in children. Abdom Radiol (NY). 2019;44:1834–1840.
doi: 10.1007/s00261-019-01903-w
Marchal-Bressenot A, Salleron J, Boulagnon-Rombi C et al. Development and validation of the Nancy histological index for UC. Gut. 2017;66:43–49.
doi: 10.1136/gutjnl-2015-310187
Mosli MH, Feagan BG, Zou G et al. Development and validation of a histological index for UC. Gut. 2017;66:50–58.
doi: 10.1136/gutjnl-2015-310393

Auteurs

François Avila (F)

Department of Radiology, University Hospital of Nancy, Vandœuvre-lès-Nancy, France.

Bénédicte Caron (B)

Department of Gastroenterology and NGERE, U1256 INSERM, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France.

Gabriela Hossu (G)

CIC 1433 Innovation Technologique, INSERM, Université de Lorraine, , CHRU Nancy, Nancy, France.
IADI, U12454, INSERM, Université de Lorraine, CHRU Nancy, Nancy, France.

Khalid Ambarki (K)

Siemens Healthcare SAS, Saint Denis, France.

Stephan Kannengiesser (S)

MR Application Predevelopment, Siemens Healthcare GmbH, Erlangen, Germany.

Freddy Odille (F)

CIC 1433 Innovation Technologique, INSERM, Université de Lorraine, , CHRU Nancy, Nancy, France.
IADI, U12454, INSERM, Université de Lorraine, CHRU Nancy, Nancy, France.

Jacques Felblinger (J)

CIC 1433 Innovation Technologique, INSERM, Université de Lorraine, , CHRU Nancy, Nancy, France.
IADI, U12454, INSERM, Université de Lorraine, CHRU Nancy, Nancy, France.

Silvio Danese (S)

Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milano, Italy.

Myriam Choukour (M)

Department of Gastroenterology and NGERE, U1256 INSERM, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France.

Valérie Laurent (V)

Department of Radiology, University Hospital of Nancy, Vandœuvre-lès-Nancy, France.
IADI, U12454, INSERM, Université de Lorraine, CHRU Nancy, Nancy, France.

Laurent Peyrin-Biroulet (L)

Department of Gastroenterology and NGERE, U1256 INSERM, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France. peyrinbiroulet@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH